经导管二尖瓣缘对缘修复治疗梗阻性肥厚型心肌病PIMSRA失败1例Transcatheter edge-to-edge mitral valve repair for the treatment of failed after PIMSRA for obstructive hypertrophic cardiomyopathy:a case report
严慧翔,林心平,徐瑶,李华俊,李晶,郁婷燕,陈晓沛,孟庆娜,梁思颖,蒲朝霞
摘要(Abstract):
本文报道1例梗阻性肥厚型心肌病经皮心肌内室间隔射频消融术治疗后7个月消融区组织未完全吸收、左心室流出道梗阻未解除并发重度二尖瓣反流的病例,利用经导管二尖瓣缘对缘修复治疗后二尖瓣反流显著减少的同时左心室流出道梗阻得到解除。望对类似病例提供借鉴。
关键词(KeyWords): 经导管二尖瓣缘对缘修复;肥厚型心肌病;经皮心肌内室间隔射频消融
基金项目(Foundation):
作者(Author): 严慧翔,林心平,徐瑶,李华俊,李晶,郁婷燕,陈晓沛,孟庆娜,梁思颖,蒲朝霞
参考文献(References):
- [1]Zou Y,Song L,Wang Z,et al.Prevalence of idiopathic hypertrophic cardiomyopathy in China:a population-based echocardiographic analysis of 8080 adults[J].Am J Med,2004,116(1):14-18.DOI:10.1016/j.amjmed.2003.05.009.
- [2]孙筱璐,王东,刘婕,等.心肌病疾病谱变化趋势研究——阜外医院门诊及住院患者数据分析[J].中国分子心脏病学杂志,2020,20(4):3477-3481.DOI:10.16563/j.cnki.1671-6272.2020.08.010.
- [3]Semsarian C,Ingles J,Maron MS,et al.New perspectives on the prevalence of hypertrophic cardiomyopathy[J].J Am Coll Cardiol,2015,65(12):1249-1254.DOI:10.1016/j.jacc.2015.01.019.
- [4]Maron MS,Olivotto I,Zenovich AG,et al.Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction[J].Circulation,2006,114(21):2232-223 9.DOI:10.1161/CIRCULATIONAHA.106.644682.
- [5] He G,Sun C,Zhang X,et al.Echocardiography-guided percutaneous per-ventricular laser ablation of ventricular septum:in vivo study in a canine model[J].Lasers Med Sci,2016,31(4):645-651.DOI:10.1007/s10103-016-1881-3.
- [6]Liu F,Fu J,Hsi D,et al.Percutaneous intramyocardial septal radiofrequency ablation for interventricular septal reduction:an ovine model with 1-year outcomes[J].Cardiology,2020,145(1):53-62.DOI:10.1159/000502973.
- [7]Liu L,Li J,Zuo L,et al.Percutaneous intramyocardial septal radiofrequency ablation for hypertrophic obstructive cardiomyopathy[J].J Am Coll Cardiol,2018,72(16):1898-1909.DOI:10.1016/j.j acc.2018.07.080.
- [8]Wang Z,Zhao R,Sievert H,et al.First-in-man application of Liwen RF~(TM)ablation system in the treatment of drug-resistant hypertrophic obstructive cardiomyopathy[J].Front Cardiovasc Med,2022,9:1028763.DOI:10.3389/fcvm.2022.1028763.
- [9]陈扬,刘洪序,陈浩,等.射频消融治疗梗阻性肥厚型心肌病有效性及安全性的系统评价和Meta分析[J].中国介入心脏病学杂志,2022,30(12):940-949.DOI:10.3969/j.issn.1004-8812.2022.12.009.
- [10]Shingu Y,Sugiki H,Ooka T,et al.Surgery for left ventricular outflow tract obstruction with a relatively thin interventricular septum[J].Thorac Cardiovasc Surg,2018,66(4):307-312.DOI:10.105 5/S-0035-1570748.
- [11]Patel P,Dhillon A,Popovic ZB,et al.Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy patients without severe septal hypertrophy:implications of mitral valve and papillary muscle abnormalities assessed using cardiac magnetic resonance and echocardiography[J].Circ Cardiovasc Imaging,2015,8(7):e003132.DOI:10.1161/CIRCIMAGING.115.003132.
- [12]石蕴琦,李占全.梗阻性肥厚型心肌病介入治疗与手术治疗的比较[J].中国介入心脏病学杂志,2015,23(5):291-293.DOI:10.3969/j.issn.1004-8812.2015.05.011.
- [13]刘丽文,左蕾,周梦垚,等.经胸超声心动图引导下经皮心肌内室间隔射频消融术治疗梗阻性肥厚型心肌病的安全性和有效性[J].中华心血管病杂志,2019,47(4):284-290.DOI:10.3760/cma.j.issn.0253-3758.2019.04.005.
- [14]Nguyen A,Schaff HV,Nishimura RA,et al.Does septal thickness influence outcome of myectomy for hypertrophic obstructive cardiomyopathy?[J].Eur J Cardiothorac Surg,2018,53(3):582-589.DOI:10.1093/ejcts/ezx398.
- [15] Hong JH,Schaff HV,Nishimura RA,et al.Mitral Regurgitation in patients with hypertrophic obstructive cardiomyopathy:implications for concomitant valve procedures[J].J Am Coll Cardiol,2016,68(14):1497-1504.DOI:10.1016/j.jacc.2016.07.735.
- [16]Lucarelli K,Troisi F,Scarcia M,et al.Transcatheter mitral valve repair for the treatment of severe mitral regurgitation and exertional pre-syncope in a patient with non-obstructive hypertrophic cardiomyopathy:a case report[J].Eur Heart J Case Rep,2021,6(1):ytab446.DOI:10.1093/ehjcr/ytab446.
- [17]Zeng J,Shu Q,Lu C,et al.The use of MitraClip for nonobstructive hypertrophic cardiomyopathy with mixed severe mitral valve regurgitation[J].ESC Heart Fail,2023,10(2):1454-1460.DOI:10.1002/ehf2.14291.
- [18] Sorajja P,Pedersen WA,Bae R,et al.First experience with percutaneousmitralvalve plication as primary therapyfor symptomatic obstructive hypertrophic cardiomyopathy[J].J Am Coll Cardiol,2016,67(24):2811-2818.DOI:10.1016/j.jacc.2016.03.587.
- [19]Bourque C,Dijos M,Leroux L,et al.Eclipsed functional mitral regurgitation destabilizing hypertrophic cardiomyopathy:an unusual case treated with MitraClip[J].CJC Open,2020,3(5):680-683.DOI:10.1016/j.cjco.2020.12.010.